Xtant Medical Inc.

AMEX: XTNT · Real-Time Price · USD
0.64
-0.01 (-1.51%)
At close: Aug 19, 2025, 10:20 AM

Xtant Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
117.27M 91.3M 57.97M 55.26M
Cost of Revenue
49.05M 35.84M 25.83M 22.77M
Gross Profit
68.22M 55.47M 32.14M 32.49M
Operating Income
-12.07M -10.16M -6.75M -3.85M
Interest Income
n/a 149K 31K n/a
Pretax Income
-16.26M -1.04M -8.42M -4.85M
Net Income
-16.45M 660K -8.48M -4.85M
Selling & General & Admin
77.91M 64.29M 37.98M 35.47M
Research & Development
2.38M 1.34M 915K 870K
Other Expenses
n/a n/a n/a n/a
Operating Expenses
80.29M 65.63M 38.89M 36.34M
Interest Expense
4.16M 2.94M 1.69M 995K
Selling & Marketing Expenses
49.21M 38.44M 22.52M 21.02M
Cost & Expenses
129.34M 101.46M 64.72M 59.12M
Income Tax Expense
187K -1.7M 69K 995K
Shares Outstanding (Basic)
133.67M 119.09M 94.09M 85.46M
Shares Outstanding (Diluted)
133.67M 126.79M 94.09M 85.46M
EPS (Basic)
-0.12 0.01 -0.09 -0.06
EPS (Diluted)
-0.12 0.01 -0.09 -0.06
EBITDA
-7.88M 5.08M -5.43M -2.51M
EBIT
-12.1M 1.9M -6.72M -3.85M
Depreciation & Amortization
4.22M 3.17M 1.3M 1.34M